Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genmab Plots $500m Nasdaq IPO

May 30 2019

• By Kevin Grogan

StatueOfLiberty — New York beckons for Genmab • Source: Shutterstock

Related Content

Darzalex Excites As Potential Grows In Multiple Myeloma

Oct 30 2018

Related Companies

Genmab A/S

Johnson & Johnson

Seagen Inc.

Bristol Myers Squibb Company

Additional Topics

Financing Business Strategies Commercial Companies Cancer BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.